No relationship was found between ER/HER2 status and tumor stage, but by tumor grade, ER+/HER2- tumors were predominantly found in pathologic grades I or II; while, HER2+ and ER-/HER2- as well as triple negative tumors were predominantly grade III. This evidence concerns the gene ERBB2 and neoplasm.